Katherine Creeper
@KJClots
Followers
140
Following
444
Media
25
Statuses
449
Haematologist. Lover of haemostasis, thrombosis and obstetrics. Ocean swimmer and amateur runner.
Joined October 2021
RT @MaryCushmanMD: Is this the end of rivaroxaban for acute VTE?.@LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban….
0
125
0
Excited already! 🇦🇺.
Check out the link below of @THANZBlood members presenting at #ISTH2025. Great to see the representation!
0
0
2
RT @APSFA: This information is designed for individuals with #asymptomatic #antiphospholipid antibodies (#APLA)—that is, those who have the….
0
2
0
RT @AryaRoopen: The much used @RCObsGyn Greentop guideline 37a is being revised. Here is a @BJOGTweets commentary from @LauraAMagee1 and t….
0
11
0
RT @mmonrealriete: A new #RIETEregistry study will appear soon in Thromb Haemost: .DOACs vs. Standard Therapy in Upper Extremity Deep Vein….
0
5
0
RT @DrKiro_Kamel: An interesting observational study showing superiority of apixaban to rivaroxaban and warfarin in terms of VTE recurrence….
0
1
0
RT @RPTHjournal: In 62 women on antepartum low-dose and postpartum high-dose thromboprophylaxis, this study reports: .6.56% major PPH.3.33%….
0
6
0
RT @TheLancet: Understanding the causes of postpartum haemorrhage is crucial to provide appropriate treatment and services. In a new stud….
0
41
0
0
0
1
RT @BloodJournal: This review uses case-based discussions to explore the management of thrombotic complications in patients with myeloproli….
0
19
0
RT @KJClots: 👇🏼👇🏼👇🏼 without the support of my @hsanz_org_au clinical fellowship grant my time at @GSTTnhs with @bhwords wouldn’t have been….
0
3
0
👇🏼👇🏼👇🏼 without the support of my @hsanz_org_au clinical fellowship grant my time at @GSTTnhs with @bhwords wouldn’t have been possible! Forever grateful for their support. 🙏🏻 Can strongly recommend to others!.
We are pleased to advise applications are now open for our PhD Scholarships and Clinical Fellowships. For more information please visit: #Leukemia #myeloma #haematology #fellowships #PhD
0
3
5
RT @WorldStrokeEd: #MondayTip. Key studies on #DOAC vs VKA in CVT. 🧠Several observational studies and small but important RCTs have evalua….
0
62
0
RT @CMichaelGibson: Late-breaker at #ACC2025: Dr. Keyvan Karkouti presented the FARES-II trial, showing superior hemostatic efficacy of PCC….
0
12
0
RT @aakonc: Practice-changing paper in @nejm by @isabellemahe1 @MarcCarrier1 API-CAT team proves that apixaban dose can be reduced after 6m….
0
56
0